Source: Annual Congress 2001 - Rare and unusual diseases or problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. P. Baranova, M. M. Ilkovitch, L. N. Novikova, I. V. Dvorakovskaya, E. M. Dembo-Smeathon, V. I. Amosov (Saint-Petersburg, Russia). Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM). Eur Respir J 2001; 16: Suppl. 31, 1527

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of aggressive course pulmonary lymphangioleiomyomatosis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients}, Source: Eur Respir J 2012; 40: 630-640 Year: 2012 Pulmonary function in patients with sporadic lymphangioleiomyomatosis. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Patient journey to diagnosis of idiopathic pulmonary fibrosis (IPF) in the US Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Idiopathic pulmonary fibrosis (IPF): the patient journey Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Pulmonary lymphangitic carcinomatosis presenting as severe interstitial lung disease in a 15-year-old female Source: Eur Respir Rev 2011; 20: 208-210 Year: 2011 Autopsy-proven causes of widespread or diffuse pulmonary infiltrates in patients with pulmonary pathology: 5 years experience Source: Eur Respir J 2006; 28: Suppl. 50, 97s Year: 2006 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Pulmonary hypertension is common in end-stage sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Video-assisted medical thoracoscopic (VAMT) lung biopsy in the diagnosis of diffuse pulmonary infiltrates Source: International Congress 2015 – Interventional pulmonology for pleural diseases Year: 2015 Results of dynamic follow-up of patients after idiopathic pulmonary embolism (PE) Source: Eur Respir J 2006; 28: Suppl. 50, 47s Year: 2006 A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Idiopathic pulmonary haemosiderosis revisited Source: Eur Respir J 2004; 24: 162-169 Year: 2004